Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study (Q53453551)

14 May 2018

title

Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study (English)

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

9 August 2024

1 reference

1

Richard B Lipton

1 reference

14 May 2018

3

David Dodick

1 reference

14 May 2018

Stephen D. Silberstein

2

object named as

Stephen Silberstein

1 reference

14 May 2018

Roger Cady

4

1 reference

14 May 2018

Fred Freitag

5

1 reference

14 May 2018

Ninan Mathew

6

1 reference

14 May 2018

Steven Ascher

8

1 reference

14 May 2018

Joseph Hulihan

10

1 reference

14 May 2018

Stephen Silberstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20974598

9 August 2024

David Dodick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20974598

9 August 2024

David M. Biondi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20974598

9 August 2024

William H. Olson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20974598

9 August 2024

language of work or name

English

0 references

publication date

17 May 2010

1 reference

14 May 2018

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/0333102410372427

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

http://journals.sagepub.com/doi/full-xml/10.1177/0333102410372427

9 August 2024

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

9 August 2024

1 reference

14 May 2018

volume

31

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

18-30

1 reference

14 May 2018

Migraine prevalence, disease burden, and the need for preventive therapy

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Modifiable risk factors for migraine progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Modifiable risk factors for migraine progression (or for chronic daily headaches)--clinical lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Burden of migraine in the United States: disability and economic costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Indirect cost burden of migraine in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Chronic disorders with episodic manifestations: focus on epilepsy and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

The prognosis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Incidence and predictors for chronicity of headache in patients with episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Ten lessons on the epidemiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

21 January 2018

Chronic daily headache

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Topiramate in migraine prevention: results of a large controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Factors associated with the onset and remission of chronic daily headache in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Chronic migraine is an earlier stage of transformed migraine in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Looking to the future: research designs for study of headache disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Chronic frequent headache in the general population: prevalence and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Excessive acute migraine medication use and migraine progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Risk factors for headache chronification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Placebo effect and clinical trials in migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Effect of active treatment is lower when using placebo control in clinical trials on acute therapy of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Lessons from placebo effects in migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Chronic Daily Headache in Taipei, Taiwan: Prevalence, Follow-Up and Outcome Predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

Chronic daily headache in adolescents: Prevalence, impact, and medication overuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410372427

The economic impact of migraine: an analysis of direct and indirect costs

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

Classification of daily and near-daily headaches: field trial of revised IHS criteria

9 August 2024

12

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

Assessing the ability of topiramate to improve the daily activities of patients with migraine

9 August 2024

27

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials

9 August 2024

28

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up

9 August 2024

29

1 reference

https://api.crossref.org/works/10.1177/0333102410372427

9 August 2024

Identifiers

1 reference

14 May 2018

1 reference

14 May 2018